NCT05435196

Brief Summary

About 382 million of adults in the world have Diabetes type 2 (DT2), and it is foreseen that this number will increase to 592 million in 2035. International Diabetes Federation (IDF) (2017) established that 352 million adults around 20 and 79 years old (which is 7,3% of that population), could be classified as prediabetes. This last is characterized by the resistance to insulin of skeletal muscle, of the liver and/ or adipose tissue, provoking the excessive e insulin secretion of β cells and pancreatic exhaustion which produce severe hyperglycemia. The High-intensity interval training (HIIT) can increase the oxidation ability, relating directly to insulin sensibility.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 26, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 28, 2022

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2024

Completed
Last Updated

August 7, 2024

Status Verified

August 1, 2024

Enrollment Period

2.2 years

First QC Date

May 26, 2022

Last Update Submit

August 5, 2024

Conditions

Keywords

prediabetic stateexercise therapywomen

Outcome Measures

Primary Outcomes (1)

  • The glycosylated hemoglobin A1c

    To determine whether the exercise training program with intervals of high intensity, endurance and neuromuscular efficiency of large muscle groups decreases the level of glycosylated hemoglobin A1c to a greater extent than the high-intensity training program in prediabetic women, considering effective a decrease 0,17%

    24 weeks

Secondary Outcomes (3)

  • The serum glucose level

    24 weeks

  • The level of maximum oxygen consumption

    24 weeks

  • The Visual Analog Scale

    24 weeks

Study Arms (2)

Experimental

EXPERIMENTAL

Get the training in with high-intensity interval exercise. Will be applied through 10 sets of 60 seconds. The first 30 seconds will consist of going up and down a step 15 cm high, immediately 30 seconds of squats as fast as possible with 90° knee flexion. The recovery period between each set will be 60 seconds, with a low-intensity activity (light walking). Based on high-intensity exercise, we must achieve an effort greater than 85% of the maximum frequency, using the heart rate meter and its equivalences with the Perceived Effort Scale (RPE). Receive a multimodal training that will consist of: resistance exercises for the main muscle groups of the extremities. In the plan, lumbopelvic, scapulothoracic and craniocervical neuromuscular efficiency exercises will also be included.

Other: Therapeutic exercise

Control

ACTIVE COMPARATOR

Get the training in with high-intensity interval exercise. Will be applied through 10 sets of 60 seconds. The first 30 seconds will consist of going up and down a step 15 cm high, immediately 30 seconds of squats as fast as possible with 90° knee flexion. The recovery period between each set will be 60 seconds, with a low-intensity activity (light walking). Based on high-intensity exercise, we must achieve an effort greater than 85% of the maximum frequency, using the heart rate meter and its equivalences with the Perceived Effort Scale (RPE).

Other: Therapeutic exercise

Interventions

The control group and the experimental group will receive the training with high-intensity interval exercise. For a period of 12 weeks both groups will participate in their exercise program, which will be supervised by the physiotherapist in charge of the study; different from the one who will carry out the randomization and the one who will perform the evaluations. Women will attend 3 times a week for an hour to the "Hospital de especialidades" to receive their exercise program in which they participated. Both groups will receive therapeutic education to encourage adherence and self-management, which include aspects such as flexibility, musculoskeletal pain, physical performance, quality of life focused on physical and mental health, etc.

Also known as: Physiotherapy
ControlExperimental

Eligibility Criteria

Age30 Years - 60 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Women diagnosed with glycosylated hemoglobin HbA1c 39-47 mmol/mol (5.7% - 6.4%), according to the primary care registry, in the last 6 months 20,21,22.
  • Women older than or equal to ≥30 to ≤60 years of age.
  • To have a body mass index (BMI) greater than or equal to 25 kg/m2.
  • Women who do not have any cognitive limitations to understand the information sheet and instructions, and freely sign the informed consent.

You may not qualify if:

  • Uncontrolled medical problems include, but are not limited to, cardiovascular, pulmonary, rheumatological, hematological, oncological, infectious, neuromuscular, or psychiatric diseases; diabetes or another endocrine disease; immunosuppression.
  • Current treatment with hormone therapy that may affect glucose metabolism.
  • Current treatment with loop diuretics or thiazide diuretics.
  • Current treatment with beta-blockers or peroral steroids.
  • Bariatric surgery in the last 2 years.
  • Women who present neuromusculoskeletal alterations that hinder or prevent the performance of the physical exercise.
  • Pregnant or lactating women.
  • Concomitant participation in another intervention study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UPAEP

Puebla City, 72410, Mexico

Location

Related Links

MeSH Terms

Conditions

Prediabetic State

Interventions

Exercise TherapyPhysical Therapy Modalities

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeutics

Study Officials

  • CLARA LUZ PEREZ QUIROGA, MCs

    Universidad UPAEP

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
Masking of the outcome variables
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: An initial evaluation, a final one, will be carried out 3 months and 6 months after the end of the study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical professor

Study Record Dates

First Submitted

May 26, 2022

First Posted

June 28, 2022

Study Start

April 1, 2022

Primary Completion

June 1, 2024

Study Completion

August 1, 2024

Last Updated

August 7, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations